WHO Working Group – Therapeutics prioritization

Overview

The current global nCoV public health emergency underscores the need to accelerate the selection and development of therapeutics for treatment and prophylaxis for COVID-19. The Working Group for therapeutics prioritization aims to provide guidance to researches to select medicines and be included in clinical trials to evaluate their efficacy again the disease. The technical advice will also serve to select the medicines to be used in the master-core protocol promoting by WHO.